Contribution Up to €4
- Starting May 2, 2025, a new contribution will be required for some prescription drugs in the Emilia-Romagna region.
- Following discussions with trade unions, regional authorities approved a resolution introducing a contribution towards pharmaceutical expenditure for residents.
- However, approximately 1.65 million residents, about one in three, will remain exempt from this payment. This includes cancer patients, individuals with chronic or rare conditions, people with disabilities,...
Emilia-Romagna Region Introduces Pharmaceutical Contribution Starting May 2
Table of Contents
- Emilia-Romagna Region Introduces Pharmaceutical Contribution Starting May 2
- Emilia-Romagna Region Pharmaceutical Contribution: Your Questions Answered
- What is the new pharmaceutical contribution in the Emilia-Romagna region?
- How much will the contribution cost?
- Who is exempt from this pharmaceutical contribution?
- Why is this new contribution being introduced?
- Are there any other changes related to healthcare in Emilia-Romagna?
- Summary of Key Changes
Starting May 2, 2025, a new contribution will be required for some prescription drugs in the Emilia-Romagna region. The reform aims to ensure the sustainability and quality of the regional health system while addressing government funding adjustments.
Following discussions with trade unions, regional authorities approved a resolution introducing a contribution towards pharmaceutical expenditure for residents. This will involve a charge of 2.20 euros per pack of medicine, up to a maximum of 4 euros per prescription.
However, approximately 1.65 million residents, about one in three, will remain exempt from this payment. This includes cancer patients, individuals with chronic or rare conditions, people with disabilities, the unemployed, and those facing economic hardship.
Regional officials stated the reform is necessary to manage the increasing pharmaceutical expenditure, which is attributed to the introduction of innovative and expensive drugs, as well as the aging population.
Authorities emphasize that this measure is designed to protect the most vulnerable members of the community.
This contribution will ensure the continued provision of quality care and strengthen services through new resources. The community’s response will serve to protect everyone, especially the most fragile.
Approximately 1.65 million residents will be exempt. This includes 373,000 individuals with chronic conditions, 766,000 facing economic hardship, and 200,000 cancer patients, transplant recipients, and those affected by rare diseases.
In addition, first specialist visits for families with at least two dependent children will remain free only for children up to the age of 14.
Emilia-Romagna Region Pharmaceutical Contribution: Your Questions Answered
What is the new pharmaceutical contribution in the Emilia-Romagna region?
Starting May 2, 2025, residents in the Emilia-Romagna region will be required to contribute towards the cost of some prescription drugs. This measure is part of a broader reform aimed at ensuring the sustainability and quality of the regional health system. This new contribution is driven by the need to manage rising pharmaceutical expenditures, which are influenced by the introduction of expensive new drugs and an aging population.
How much will the contribution cost?
The contribution amounts to 2.20 euros per pack of medicine, capped at a maximum of 4 euros per prescription.
Who is exempt from this pharmaceutical contribution?
Approximately 1.65 million residents, representing about one in three people in the region, are exempt from this payment. The exemptions include:
- Cancer patients
- Individuals with chronic or rare conditions (373,000 individuals)
- People with disabilities
- The unemployed
- Those facing economic hardship (766,000 individuals)
- Transplant recipients and those affected by rare diseases (included within the 200,000 group)
Why is this new contribution being introduced?
Regional authorities state that the reform is necessary to manage the increasing costs of pharmaceutical spending. These rising costs are due to the rise of innovative and often more expensive drugs, coupled with the demographic shift of an aging population. This measure aims to ensure the continued provision of quality care and to strengthen health services.
“This contribution will ensure the continued provision of quality care and strengthen services through new resources. The community’s response will serve to protect everyone, especially the most fragile.”
Yes, along with the pharmaceutical contribution, first specialist visits will remain free for families with at least two dependent children, but only if the children are up to the age of 14.
Summary of Key Changes
| Aspect | Details |
|---|---|
| Implementation Date | May 2, 2025 |
| Contribution | 2.20 euros per pack (max 4 euros per prescription) |
| Residents Exempt | Approx. 1.65 million (approx. one-third of the population) |
| Exemptions include | Cancer patients, chronic or rare conditions, disabilities, unemployed, economic hardship |
| Other change | Free Specialist visits for families with at least two dependent children, only if the children are up to the age of 14. |